Two Sigma Investments, LP Bluebird Bio, Inc. Transaction History

Two Sigma Investments, LP

$42.3 Billion
Q3 2024

A detailed history of Two Sigma Investments, LP transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 450,091 shares of BLUE stock, worth $4.13 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

450,091

Previous 907,977 50.43%

Holding current value

$4.13 Million

Previous $889,000 73.68%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.47 - $1.35 $215,206 - $618,146	-457,886 Reduced 50.43%	450,091 $234,000
Q2 2024 Aug 14, 2024	SELL	$0.85 - $1.26 $1.59 Million - $2.35 Million	-1,866,065 Reduced 67.27%	907,977 $889,000
Q1 2024 May 15, 2024	SELL	$0.91 - $1.75 $124,460 - $239,347	-136,770 Reduced 4.7%	2,774,042 $3.55 Million
Q4 2023 Feb 14, 2024	BUY	$1.32 - $4.83 $3.84 Million - $14.1 Million	2,910,812 New	2,910,812 $4.02 Million
Q2 2023 Aug 14, 2023	BUY	$2.79 - $5.03 $470,374 - $848,022	168,593 New	168,593 $554,000
Q2 2022 Aug 15, 2022	SELL	$2.94 - $5.23 $894,009 - $1.59 Million	-304,085 Reduced 37.1%	515,549 $2.13 Million
Q1 2022 May 16, 2022	BUY	$4.07 - $10.6 $2.64 Million - $6.88 Million	648,941 Added 380.18%	819,634 $3.98 Million
Q4 2021 Feb 14, 2022	BUY	$8.96 - $16.31 $1.53 Million - $2.78 Million	170,693 New	170,693 $1.71 Million
Q2 2021 Aug 16, 2021	SELL	$18.04 - $22.09 $4.13 Million - $5.05 Million	-228,802 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$16.59 - $33.89 $3.6 Million - $7.34 Million	216,712 Added 1792.49%	228,802 $6.9 Million
Q4 2020 Feb 16, 2021	SELL	$27.5 - $37.92 $1.32 Million - $1.83 Million	-48,140 Reduced 79.93%	12,090 $523,000
Q3 2020 Nov 16, 2020	BUY	$34.44 - $43.75 $2.07 Million - $2.64 Million	60,230 New	60,230 $3.25 Million
Q2 2020 Aug 14, 2020	SELL	$27.12 - $45.97 $3.53 Million - $5.98 Million	-130,127 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$26.16 - $63.5 $3.4 Million - $8.26 Million	130,127 New	130,127 $5.98 Million
Q3 2019 Nov 14, 2019	SELL	$59.47 - $93.1 $1.79 Million - $2.81 Million	-30,175 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$75.84 - $105.21 $2.29 Million - $3.17 Million	30,175 New	30,175 $3.84 Million
Q1 2019 May 15, 2019	SELL	$64.44 - $104.11 $16.5 Million - $26.6 Million	-255,290 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$59.1 - $93.26 $15.1 Million - $23.8 Million	255,290 New	255,290 $25.3 Million
Q1 2018 May 15, 2018	SELL	$105.8 - $150.94 $9.25 Million - $13.2 Million	-87,461 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$81.25 - $130.7 $197,437 - $317,601	2,430 Added 2.86%	87,461 $15.6 Million
Q3 2017 Nov 14, 2017	BUY	$57.74 - $91.42 $4.91 Million - $7.77 Million	85,031	85,031 $11.7 Million

Others Institutions Holding BLUE

# of Institutions

150

Shares Held

63.4M

Call Options Held

264K

Put Options Held

428K

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $708M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Bluebird Bio, Inc. Transaction History